FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311045416> ?p ?o ?g. }

• W4311045416 endingPage "1979" @default.
• W4311045416 startingPage "1979" @default.
• W4311045416 abstract "Neurodegenerative disorders (NDDs), such as Alzheimer’s disease (AD) and Parkinson’s Disease (PD), are a group of heterogeneous diseases that mainly affect central nervous system (CNS) functions. A subset of NDDs exhibit CNS dysfunction and muscle degeneration, as observed in Gangliosidosis 1 (GM1) and late stages of PD. Neuromuscular disorders (NMDs) are a group of diseases in which patients show primary progressive muscle weaknesses, including Duchenne Muscular Dystrophy (DMD), Pompe disease, and Spinal Muscular Atrophy (SMA). NDDs and NMDs typically have a genetic component, which affects the physiological functioning of critical cellular processes, leading to pathogenesis. Currently, there is no cure or efficient treatment for most of these diseases. More than 200 clinical trials have been completed or are currently underway in order to establish safety, tolerability, and efficacy of promising gene therapy approaches. Thus, gene therapy-based therapeutics, including viral or non-viral delivery, are very appealing for the treatment of NDDs and NMDs. In particular, adeno-associated viral vectors (AAV) are an attractive option for gene therapy for NDDs and NMDs. However, limitations have been identified after systemic delivery, including the suboptimal capacity of these therapies to traverse the blood–brain barrier (BBB), degradation of the particles during the delivery, high reactivity of the patient’s immune system during the treatment, and the potential need for redosing. To circumvent these limitations, several preclinical and clinical studies have suggested intrathecal (IT) delivery to target the CNS and peripheral organs via cerebrospinal fluid (CSF). CSF administration can vastly improve the delivery of small molecules and drugs to the brain and spinal cord as compared to systemic delivery. Here, we review AAV biology and vector design elements, different therapeutic routes of administration, and highlight CSF delivery as an attractive route of administration. We discuss the different aspects of neuromuscular and neurodegenerative diseases, such as pathogenesis, the landscape of mutations, and the biological processes associated with the disease. We also describe the hallmarks of NDDs and NMDs as well as discuss current therapeutic approaches and clinical progress in viral and non-viral gene therapy and enzyme replacement strategies for those diseases." @default.
• W4311045416 created "2022-12-23" @default.
• W4311045416 creator A5031054202 @default.
• W4311045416 creator A5033024298 @default.
• W4311045416 creator A5054034757 @default.
• W4311045416 creator A5063666811 @default.
• W4311045416 creator A5076413800 @default.
• W4311045416 creator A5086564788 @default.
• W4311045416 date "2022-11-30" @default.
• W4311045416 modified "2023-10-14" @default.
• W4311045416 title "Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders" @default.
• W4311045416 cites W139811396 @default.
• W4311045416 cites W1534628288 @default.
• W4311045416 cites W1553052228 @default.
• W4311045416 cites W1626583747 @default.
• W4311045416 cites W1786920819 @default.
• W4311045416 cites W1838526658 @default.
• W4311045416 cites W1947548159 @default.
• W4311045416 cites W1964864637 @default.
• W4311045416 cites W1968006472 @default.
• W4311045416 cites W1973095007 @default.
• W4311045416 cites W1974029377 @default.
• W4311045416 cites W1978221944 @default.
• W4311045416 cites W1984841297 @default.
• W4311045416 cites W1989073393 @default.
• W4311045416 cites W1989992777 @default.
• W4311045416 cites W1994495694 @default.
• W4311045416 cites W1996412713 @default.
• W4311045416 cites W1999113624 @default.
• W4311045416 cites W2001979917 @default.
• W4311045416 cites W2002213747 @default.
• W4311045416 cites W2003200494 @default.
• W4311045416 cites W2004590552 @default.
• W4311045416 cites W2005218288 @default.
• W4311045416 cites W2005291427 @default.
• W4311045416 cites W2011950472 @default.
• W4311045416 cites W2013766668 @default.
• W4311045416 cites W2014850190 @default.
• W4311045416 cites W2016855436 @default.
• W4311045416 cites W2019247095 @default.
• W4311045416 cites W2020278806 @default.
• W4311045416 cites W2020792282 @default.
• W4311045416 cites W2021772330 @default.
• W4311045416 cites W2027764735 @default.
• W4311045416 cites W2033602138 @default.
• W4311045416 cites W2036591210 @default.
• W4311045416 cites W2041359471 @default.
• W4311045416 cites W2045600222 @default.
• W4311045416 cites W2047000182 @default.
• W4311045416 cites W2050581000 @default.
• W4311045416 cites W2053858663 @default.
• W4311045416 cites W2056602419 @default.
• W4311045416 cites W2058010019 @default.
• W4311045416 cites W2061013034 @default.
• W4311045416 cites W2065380345 @default.
• W4311045416 cites W2066993089 @default.
• W4311045416 cites W2082429191 @default.
• W4311045416 cites W2085717798 @default.
• W4311045416 cites W2086110738 @default.
• W4311045416 cites W2092096067 @default.
• W4311045416 cites W2092757238 @default.
• W4311045416 cites W2100199292 @default.
• W4311045416 cites W2113259183 @default.
• W4311045416 cites W2113630941 @default.
• W4311045416 cites W2116086639 @default.
• W4311045416 cites W2135793292 @default.
• W4311045416 cites W2139601009 @default.
• W4311045416 cites W2143609092 @default.
• W4311045416 cites W2144021643 @default.
• W4311045416 cites W2145986851 @default.
• W4311045416 cites W2149731696 @default.
• W4311045416 cites W2149930154 @default.
• W4311045416 cites W2152594308 @default.
• W4311045416 cites W2161841050 @default.
• W4311045416 cites W2166739815 @default.
• W4311045416 cites W2167659424 @default.
• W4311045416 cites W2169621456 @default.
• W4311045416 cites W2170205772 @default.
• W4311045416 cites W2176154815 @default.
• W4311045416 cites W2193401968 @default.
• W4311045416 cites W2201116758 @default.
• W4311045416 cites W2206045884 @default.
• W4311045416 cites W2235262685 @default.
• W4311045416 cites W2263743937 @default.
• W4311045416 cites W2324542890 @default.
• W4311045416 cites W2324878797 @default.
• W4311045416 cites W2339791932 @default.
• W4311045416 cites W2409520973 @default.
• W4311045416 cites W2412368354 @default.
• W4311045416 cites W2419387337 @default.
• W4311045416 cites W2442729673 @default.
• W4311045416 cites W2488746878 @default.
• W4311045416 cites W2527794060 @default.
• W4311045416 cites W2528854795 @default.
• W4311045416 cites W2534981988 @default.
• W4311045416 cites W2564421461 @default.
• W4311045416 cites W2593167039 @default.
• W4311045416 cites W2599295022 @default.

• next